{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T12:25:59Z","timestamp":1787142359734,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T00:00:00Z","timestamp":1757808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jcrc.2025.155264","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:47:53Z","timestamp":1758088073000},"page":"155264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Target attainment with continuously administered cefotaxime in critically ill patients \u2013 a retrospective cohort study"],"prefix":"10.1016","volume":"91","author":[{"given":"C.","family":"Stephani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wieditz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Streit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lanckohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Scheithauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Moerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2025.155264_bb0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00003088-199834010-00002","article-title":"Pharmacokinetics of drugs used in critically ill adults","volume":"34","author":"Power","year":"1998","journal-title":"Clin Pharmacokinet [Internet]"},{"key":"10.1016\/j.jcrc.2025.155264_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00007691-198109000-00009","article-title":"Pharmacokinetics of intravenous cefotaxime in patients undergoing chronic hemodialysis","volume":"3","author":"Chodos","year":"1981","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jcrc.2025.155264_bb0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00003495-199753030-00009","article-title":"Cefotaxime: a reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections","volume":"53","author":"Brogden","year":"1997","journal-title":"Drugs [Internet]"},{"key":"10.1016\/j.jcrc.2025.155264_bb0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00007691-198709000-00002","article-title":"Influence of gender on the disposition of cefotaxime and desacetylcefotaxime","volume":"9","author":"Guay","year":"1987","journal-title":"Ther Drug Monit"},{"issue":"Suppl. 3","key":"10.1016\/j.jcrc.2025.155264_bb0025","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.cmi.2016.01.007","article-title":"ESCMID guideline: diagnosis and treatment of acute bacterial meningitis","volume":"22","author":"van de Beek","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jcrc.2025.155264_bb0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/clinids\/14.1.56","article-title":"Safety profile and efficacy of cefotaxime for the treatment of hospitalized children","volume":"14","author":"Jacobs","year":"1992","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jcrc.2025.155264_bb0035","first-page":"275","article-title":"The safety and pharmacokinetics of cefotaxime in the treatment of neonates","volume":"2","author":"de Louvois","year":"1982","journal-title":"Pediatr Pharmacol N Y N"},{"key":"10.1016\/j.jcrc.2025.155264_bb0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13318-017-0439-5","article-title":"Continuous infusion versus intermittent bolus of beta-lactams in critically ill patients with respiratory infections: a systematic review and meta-analysis","volume":"43","author":"Lee","year":"2018","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jcrc.2025.155264_bb0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2165\/00003088-200544020-00005","article-title":"Pharmacokinetic\/pharmacodynamic modelling of antibacterials in vitro and in vivo using bacterial growth and kill kinetics: the minimum inhibitory concentration versus stationary concentration","volume":"44","author":"Mouton","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jcrc.2025.155264_bb0050","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2025.155264_bb0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2110-5820-2-35","article-title":"Does beta-lactam pharmacokinetic variability in critically ill patients justify therapeutic drug monitoring? A systematic review","volume":"2","author":"Sime","year":"2012","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jcrc.2025.155264_bb0060","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhin.2023.10.016","article-title":"Drug monitoring during ciprofloxacin prophylaxis of allogeneic stem cell transplant patients: associations with bacterial infections through a monocentric observational prospective study","volume":"143","author":"Kaba","year":"2024","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jcrc.2025.155264_bb0065","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#","volume":"46","author":"the Infection Section of European Society of Intensive Care Medicine (ESICM), Pharmacokinetic\/pharmacodynamic and Critically Ill Patient Study Groups of European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Group of International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT), Infections in the ICU and Sepsis Working Group of International Society of Antimicrobial Chemotherapy (ISAC)","year":"2020","journal-title":"Intensive Care Med [Internet]"},{"key":"10.1016\/j.jcrc.2025.155264_bb0070","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/bcp.15487","article-title":"Dose optimization of cefotaxime as pre-emptive treatment in critically ill adult patients: a population pharmacokinetic study","volume":"89","author":"Roelofsen","year":"2023","journal-title":"Br J Clin Pharmacol [Internet]"},{"key":"10.1016\/j.jcrc.2025.155264_bb0075","doi-asserted-by":"crossref","first-page":"21891","DOI":"10.1038\/s41598-022-25967-9","article-title":"Low attainment to PK\/PD-targets for \u03b2-lactams in a multi-center study on the first 72 h of treatment in ICU patients","volume":"12","author":"Smekal","year":"2022","journal-title":"Sci Rep [Internet]"},{"key":"10.1016\/j.jcrc.2025.155264_bb0080","first-page":"441","article-title":"Continuous versus intermittent infusion of cefotaxime in critically ill patients: a randomized controlled trial comparing plasma concentrations","volume":"75","author":"Aardema","year":"2020","journal-title":"J Antimicrob Chemother [Internet]"},{"key":"10.1016\/j.jcrc.2025.155264_bb0085","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40262-017-0602-9","article-title":"Population pharmacokinetic model to optimize cefotaxime dosing regimen in critically ill children","volume":"57","author":"B\u00e9ranger","year":"2018","journal-title":"Clin Pharmacokinet [Internet]"},{"key":"10.1016\/j.jcrc.2025.155264_bb0090","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00431-022-04716-0","article-title":"Beta-lactam exposure and safety in intermittent or continuous infusion in critically ill children: an observational monocenter study","volume":"182","author":"Debray","year":"2023","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jcrc.2025.155264_bb0095","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/jama.2024.9803","article-title":"Prolonged vs intermittent infusions of \u03b2-lactam antibiotics in adults with sepsis or septic shock: a systematic review and meta-analysis","volume":"332","author":"Abdul-Aziz","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2025.155264_bb0100","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.9779","article-title":"Continuous vs intermittent \u03b2-lactam antibiotic infusions in critically ill patients with sepsis: the BLING III randomized clinical trial","author":"Dulhunty","year":"2024","journal-title":"JAMA [Internet]"},{"key":"10.1016\/j.jcrc.2025.155264_bb0105","author":"Makowski"},{"key":"10.1016\/j.jcrc.2025.155264_bb0110","author":"Miller"},{"key":"10.1016\/j.jcrc.2025.155264_bb0115","first-page":"313","article-title":"Dosing regimen for cefotaxime should be adapted to the stage of renal dysfunction in critically ill adult patients-a retrospective study","volume":"13","author":"Dillies","year":"2024","journal-title":"Antibiot Basel Switz"},{"key":"10.1016\/j.jcrc.2025.155264_bb0120","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1186\/s13054-020-03272-z","article-title":"Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT)","volume":"24","author":"Abdulla","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2025.155264_bb0125","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3390\/antibiotics12081289","article-title":"\u03b2-lactam pharmacokinetic\/pharmacodynamic target attainment in intensive care unit patients: a prospective, observational, cohort study","volume":"12","author":"Guilhaumou","year":"2023","journal-title":"Antibiotics [Internet]"},{"key":"10.1016\/j.jcrc.2025.155264_bb0130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00228-021-03218-6","article-title":"Population pharmacokinetics of cefotaxime in intensive care patients","volume":"78","author":"Swartling","year":"2022","journal-title":"Eur J Clin Pharmacol [Internet]"},{"key":"10.1016\/j.jcrc.2025.155264_bb0135","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1093\/jac\/dkac168","article-title":"Optimal dosing of cefotaxime and desacetylcefotaxime for critically ill paediatric patients. Can we use microsampling?","volume":"77","author":"Guerra Valero","year":"2022","journal-title":"J Antimicrob Chemother [Internet]"},{"key":"10.1016\/j.jcrc.2025.155264_bb0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF01686851","article-title":"Cefotaxime in treatment of meningitis and ventriculitis? Evaluation of drug concentrations in human cerebrospinal fluid","volume":"8","author":"Br\u00fcckner","year":"1982","journal-title":"Intensive Care Med [Internet]"}],"updated-by":[{"DOI":"10.1016\/j.jcrc.2025.155307","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000}},{"DOI":"10.1016\/j.jcrc.2025.155307","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000}}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944125002515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944125002515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:39:14Z","timestamp":1787139554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944125002515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":28,"alternative-id":["S0883944125002515"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2025.155264","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Target attainment with continuously administered cefotaxime in critically ill patients \u2013 a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2025.155264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"155264"}}